stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
무료 - Play StoreApp Store
설치하다설치하다
logo
Dow:  
Nasdaq:  
S&P 500:  
Enliven Therapeutics IncELVN
$44.580.75%0.33
시간 외 거래: 44.63+0.05 +0.11%

Enliven Therapeutics Inc (ELVN)

Date: 2026-11-02 16:00O: 44.48H: 45.06L: 43.23C: 44.58Vol: 708.7k
전일 마감가:
$44.25
열려 있는:
$44.48
하루 거래량:
708,723
상대 거래량:
0.38
시가총액:
$3.27B
수익:
-
순이익/손실:
-$98.78M
주가수익비율:
-
EPS:
-$1.66
순현금흐름:
-$65.60M
1W 성능:
+7.45%
1M 성능:
-5.09%
6M 성능:
+6.91%
1Y 성능:
+90.35%
1일 변동 폭
$43.23$45.06
1주일 범위
$41.52$45.87
52주 변동 폭
$14.79$62.32

Enliven Therapeutics Inc 주식 (ELVN) 회사 개요

명칭
Enliven Therapeutics Inc
전화
720-647-8519
주소
6200 LOOKOUT ROAD, BOULDER, USA
직원
60
X
-
다음 수익 날짜
2026-11-11
최신 SEC 제출 서류
SEC
X에서 ELVN에 대한 토론
X

ELVN vs VRTX, REGN, MRNA, ARGX, ONC 비교

주식시가총액매출순이익현금흐름주당 순 이익
ELVN
Enliven Therapeutics Inc
$3.27B$0-$105.93M-$67.04M-$1.66
VRTX
Vertex Pharmaceuticals Inc
$140.94B$12.59B$4.41B$3.80B$16.87
REGN
Regeneron Pharmaceuticals Inc
$99.46B$16.90B$4.82B$3.83B$41.04
MRNA
Moderna Inc
$88.17B$2.23B-$3.15B-$1.24B-$8.15
ARGX
Argen X Se Adr
$55.03B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$40.86B$6.13B$655.71M$1.33B$4.48

Enliven Therapeutics Inc 주식(ELVN) 업그레이드 및 다운그레이드

날짜액션분석자등급 변경
2026-10-02개시Morgan StanleyOverweight
2026-10-01개시JP MorganOverweight
2026-08-18개시BarclaysOverweight
2026-08-18개시William BlairOutperform

Enliven Therapeutics Inc (ELVN) 재무 분석

기간추세FY 2025FY 2024FY 2023FY 2022FY 2021
기간 종료일2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)--0.00--
Research and development USD (M)85.8680.7864.5718.9438.44
Operating expenses USD (M)119.66104.5583.5334.2751.44
Operating income USD (M)-119.66-104.55-83.530.73-51.44
Income before tax USD (M)---71.581.58-
Income tax expense USD (M)0.000.230.000.09-
Net income USD (M)-103.69-89.02-71.581.49-51.38
Basic EPS USD/shares-1.83-1.89-2.010.06-
Diluted EPS USD/shares-1.83-1.89-2.010.06-
Basic weighted shares shares (M)56.6647.0735.5526.29-
Diluted weighted shares shares (M)56.6647.0735.5526.39-

Enliven Therapeutics Inc 주식 (ELVN) 내부자 거래

  • Hohl BenjaminOct 19 '26
    CHIEF FINANCIAL OFFICER
    거래
    Sale
    비용
    $38.48
    #주식
    6,018
    가치 ($)
    231,546
    #주식 총계
    38,000
  • Director
    거래
    Proposed Sale
    비용
    $37.32
    #주식
    15,000
    가치 ($)
    559,800
    #주식 총계
    0
  • Hohl BenjaminOct 19 '26
    CHIEF FINANCIAL OFFICER
    거래
    Option Exercise
    비용
    $14.85
    #주식
    6,018
    가치 ($)
    89,367
    #주식 총계
    44,018
  • CHIEF MEDICAL OFFICER
    거래
    Sale
    비용
    $38.47
    #주식
    5,000
    가치 ($)
    192,342
    #주식 총계
    25,000
  • CHIEF MEDICAL OFFICER
    거래
    Option Exercise
    비용
    $2.48
    #주식
    5,000
    가치 ($)
    12,400
    #주식 총계
    30,000
  • Director
    거래
    Sale
    비용
    $46.67
    #주식
    13,000
    가치 ($)
    606,719
    #주식 총계
    0
  • Director
    거래
    Option Exercise
    비용
    $15.47
    #주식
    13,000
    가치 ($)
    201,110
    #주식 총계
    13,000
  • JEFFREY GARLANDOct 01 '26
    Director
    거래
    Proposed Sale
    비용
    $46.67
    #주식
    13,000
    가치 ($)
    606,719
    #주식 총계
    0
  • CHIEF MEDICAL OFFICER
    거래
    Sale
    비용
    $50.35
    #주식
    5,000
    가치 ($)
    251,754
    #주식 총계
    25,000
  • CHIEF MEDICAL OFFICER
    거래
    Option Exercise
    비용
    $2.48
    #주식
    5,000
    가치 ($)
    12,400
    #주식 총계
    30,000
내부자 거래관계날짜거래비용#주식가치 ($)#주식 총계
Hohl BenjaminCHIEF FINANCIAL OFFICEROct 19 '26Sale$38.486,018231,54638,000
Collins Helen LouiseDirectorOct 19 '26Proposed Sale$37.3215,000559,8000
Hohl BenjaminCHIEF FINANCIAL OFFICEROct 19 '26Option Exercise$14.856,01889,36744,018
Collins Helen LouiseCHIEF MEDICAL OFFICEROct 19 '26Sale$38.475,000192,34225,000
Collins Helen LouiseCHIEF MEDICAL OFFICEROct 19 '26Option Exercise$2.485,00012,40030,000
Garland J. ScottDirectorOct 01 '26Sale$46.6713,000606,7190
Garland J. ScottDirectorOct 01 '26Option Exercise$15.4713,000201,11013,000
JEFFREY GARLANDDirectorOct 01 '26Proposed Sale$46.6713,000606,7190
Collins Helen LouiseCHIEF MEDICAL OFFICERSep 17 '26Sale$50.355,000251,75425,000
Collins Helen LouiseCHIEF MEDICAL OFFICERSep 17 '26Option Exercise$2.485,00012,40030,000

Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스

Oct 27, 2026
Oct 27, 2026
Oct 23, 2026
Oct 23, 2026
Oct 22, 2026
Oct 22, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 19, 2026
Oct 19, 2026
Oct 17, 2026
Oct 17, 2026
Oct 16, 2026
Oct 16, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 05, 2026
Oct 05, 2026
Oct 01, 2026
Oct 01, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 17, 2026
Sep 17, 2026
Sep 10, 2026
Sep 10, 2026
Sep 08, 2026
Sep 08, 2026
Sep 04, 2026
Sep 04, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 30, 2026
Aug 30, 2026
Aug 25, 2026
Aug 25, 2026
Aug 21, 2026
Aug 21, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026

ELVN와(과) 유사한 종목